<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04735224</url>
  </required_header>
  <id_info>
    <org_study_id>HMCampo2</org_study_id>
    <nct_id>NCT04735224</nct_id>
  </id_info>
  <brief_title>Complications After Endoscopic Retrograde Cholangiopancreatography</brief_title>
  <acronym>ERCP</acronym>
  <official_title>Long-term Risks After Endoscopic Retrograde Cholangiopancreatography (ERCP) With Sphincterotomy.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Juan Carlos Martín del Olmo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Medina del Campo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Retrospective study to analyze benign complications and malignancy risks after ERCP with&#xD;
      sphincterotomy. All patients who received a ERCP with sphincterotomy for a benign disease&#xD;
      will be included. Post-ERCP hepato-biliary complications in the follow-up will be registered.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a single center retrospective study. All patients that received an ERCP with&#xD;
      sphincterotomy for a benign disease from 1995 will be included.&#xD;
&#xD;
      The exclusion criteria are diagnosis of primary malignant tumors in the liver, bile ducts&#xD;
      including peri-ampullary region and pancreas in the ERCP. Loss of follow-up less than two&#xD;
      years after the ERCP and biliopancreatic malignancy diagnostic in this period. The initial&#xD;
      work-up included laboratory test, ultrasound scan and, when precise, computed tomography (CT)&#xD;
      and magnetic resonance image (MRI).&#xD;
&#xD;
      The data collected will be:&#xD;
&#xD;
        1. Age, sex, comorbidities, long of hospital stay.&#xD;
&#xD;
        2. ERCP indications.&#xD;
&#xD;
        3. ERCP sphincterotomy or precut, biliary stent insertion and type of stent.&#xD;
&#xD;
        4. post-ERCP diagnosis, abnormal diameter of biliary tree.&#xD;
&#xD;
        5. ERCP repetition and causes.&#xD;
&#xD;
        6. Immediate complications like bleeding, residual choledocholithiasis, ascending&#xD;
           cholangitis, pancreatitis, and cholecystitis, and their number after more than two&#xD;
           months.&#xD;
&#xD;
        7. Malignant complications after more than two years: cholangiocarcinoma, hepatocarcinoma&#xD;
           and ductal pancreatic adenocarcinoma.&#xD;
&#xD;
      Stistical analyses will be performed using SPSS, ver. 25.0 (SPSS Inc., Chicago Illinois,&#xD;
      USA). The demographics, perioperative data, operation details, length of hospital stay,&#xD;
      morbidity, mortality and pathologic and oncological outcomes are expressed as numbers and&#xD;
      percentages for qualitative variables and medians and interquartile ranges (IQRs) for&#xD;
      quantitative variables.&#xD;
&#xD;
      Univariate and multivariate logistic regression analyses will be employed to determine the&#xD;
      risk factors for the development short-term and long-term complications. Variables with P&lt;0.1&#xD;
      in the univariate analysis will be further introduced into the multivariate analysis with the&#xD;
      Wald selection method. P values &lt; 0.05 were considered statistically significant.&#xD;
&#xD;
      This study involved the use of data from clinical records. To guarantee the proper handling&#xD;
      of the information, the data were treated confidentially and anonymously according to the&#xD;
      provisions of the Spanish Organic Law 15/1999, of 13 December 1999, on Personal Data&#xD;
      Protection (LOPD). All methods were performed in accordance with the guidelines and&#xD;
      regulations established by the Declaration of Helsinki (1964, revised in 1983) on biomedical&#xD;
      research in humans, the Spanish Royal Decree 1090/2015, of December 4, which regulates&#xD;
      clinical trials with drugs, the Research Ethics Committees with drugs and the Spanish&#xD;
      Registry of Clinical Studies. Ethical approval from the Clinical Trials and Ethics Committee&#xD;
      of Valladolid University was granted.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2017</start_date>
  <completion_date type="Actual">December 20, 2020</completion_date>
  <primary_completion_date type="Actual">October 10, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>long-term complications after ERCP with sphincterotomy</measure>
    <time_frame>10 years</time_frame>
    <description>Long- terms complications registered</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>characteristics of patients who develop complications after endoscopy sphincterotomy</measure>
    <time_frame>10 years</time_frame>
    <description>defined characteristics</description>
  </secondary_outcome>
  <other_outcome>
    <measure>association between ERCP with sphincterotomy and the development of neoplasm in the bile ducts</measure>
    <time_frame>10 years</time_frame>
    <description>risks of malignancy</description>
  </other_outcome>
  <enrollment type="Actual">500</enrollment>
  <condition>Choledocholithiasis With Acute Cholangitis (Diagnosis)</condition>
  <condition>Acute Pancreatitis Due to Gallstones</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients having undergone ERCP with sphincterotomy for benign diseases between 1995 and&#xD;
        2015&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients having undergone ERCP with sphincterotomy for benign diseases between 1995&#xD;
             and 2015&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of primary malignant tumors in the liver, bile ducts including ampullary&#xD;
             region, and pancreas in the ERCP test.&#xD;
&#xD;
          -  Patients with follow-up less than two years after the ERCP and biliopancreatic&#xD;
             malignancy diagnostic in this period.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Juan Carlos Martin Del Olmo, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Hospital Medina del Campo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mercedes Ibáñez García, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Medina del Campo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Carlos Guijarro, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital Medina del Campo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kostantin Shirai, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital Medina del Campo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Cristina López Mestanza, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital Medina del Campo</affiliation>
  </overall_official>
  <reference>
    <citation>McCune WS, Shorb PE, Moscovitz H. Endoscopic cannulation of the ampulla of vater: a preliminary report. Ann Surg. 1968 May;167(5):752-6.</citation>
    <PMID>5646296</PMID>
  </reference>
  <reference>
    <citation>Nakajima M, Kimoto K, Fukumoto K, Ikehara H, Kawai K. Endoscopic sphincterotomy of the ampulla of Vater and removal of common duct stones. Am J Gastroenterol. 1975 Jul;64(1):34-43.</citation>
    <PMID>1155423</PMID>
  </reference>
  <reference>
    <citation>Oliveira-Cunha M, Dennison AR, Garcea G. Late Complications After Endoscopic Sphincterotomy. Surg Laparosc Endosc Percutan Tech. 2016 Feb;26(1):1-5. doi: 10.1097/SLE.0000000000000226. Review.</citation>
    <PMID>26679684</PMID>
  </reference>
  <reference>
    <citation>ASGE Standards of Practice Committee, Chathadi KV, Chandrasekhara V, Acosta RD, Decker GA, Early DS, Eloubeidi MA, Evans JA, Faulx AL, Fanelli RD, Fisher DA, Foley K, Fonkalsrud L, Hwang JH, Jue TL, Khashab MA, Lightdale JR, Muthusamy VR, Pasha SF, Saltzman JR, Sharaf R, Shaukat A, Shergill AK, Wang A, Cash BD, DeWitt JM. The role of ERCP in benign diseases of the biliary tract. Gastrointest Endosc. 2015 Apr;81(4):795-803. doi: 10.1016/j.gie.2014.11.019. Epub 2015 Feb 7.</citation>
    <PMID>25665931</PMID>
  </reference>
  <reference>
    <citation>ASGE Standards of Practice Committee, Chandrasekhara V, Khashab MA, Muthusamy VR, Acosta RD, Agrawal D, Bruining DH, Eloubeidi MA, Fanelli RD, Faulx AL, Gurudu SR, Kothari S, Lightdale JR, Qumseya BJ, Shaukat A, Wang A, Wani SB, Yang J, DeWitt JM. Adverse events associated with ERCP. Gastrointest Endosc. 2017 Jan;85(1):32-47. doi: 10.1016/j.gie.2016.06.051. Epub 2016 Aug 18. Review.</citation>
    <PMID>27546389</PMID>
  </reference>
  <reference>
    <citation>Sung JY, Leung JW, Shaffer EA, Lam K, Olson ME, Costerton JW. Ascending infection of the biliary tract after surgical sphincterotomy and biliary stenting. J Gastroenterol Hepatol. 1992 May-Jun;7(3):240-5.</citation>
    <PMID>1611012</PMID>
  </reference>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>December 22, 2020</study_first_submitted>
  <study_first_submitted_qc>January 31, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 3, 2021</study_first_posted>
  <last_update_submitted>January 31, 2021</last_update_submitted>
  <last_update_submitted_qc>January 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Medina del Campo</investigator_affiliation>
    <investigator_full_name>Juan Carlos Martín del Olmo</investigator_full_name>
    <investigator_title>MD, PhD. Associate Profesor Valladolid University</investigator_title>
  </responsible_party>
  <keyword>ERCP</keyword>
  <keyword>ERCP complications</keyword>
  <keyword>Endoscopic Sphincterotomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatitis</mesh_term>
    <mesh_term>Cholangitis</mesh_term>
    <mesh_term>Gallstones</mesh_term>
    <mesh_term>Choledocholithiasis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 22, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/24/NCT04735224/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

